The trademark application BRIPTUREF was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on September 29, 2022, and it was registered by office on January 6, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).